Latest California Healthline Stories
Sarah Kliff of Vox.com, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the latest version of a “Medicare-for-all” bill by Sen. Bernie Sanders (I-Vt.), a presidential hopeful, and Democratic and Republican reactions to it. They also discuss the latest on congressional efforts to rein in drug prices and another state effort to expand Medicaid — but not exactly in the way voters wanted. Also, Rovner interviews Ceci Connolly of the Alliance of Community Health Plans.
Older adults — and their families — often find it challenging and stressful to find the best facility. And they often end up in the wrong spot, new research shows.
“Medicare for America” seeks to avoid some of the predictable obstacles of a full-blown expansion of Medicare. Can it survive the politics of health reform?
During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.
Celina, Tenn., has long lured retirees, with its scenic hills and affordability. These newcomers help fuel the local economy. But a recent hospital closure makes the town a harder sell.
In a nation where the suicide rate continues to climb, such deaths among older adults are often overlooked. A six-month investigation by KHN and PBS NewsHour finds that older Americans are quietly killing themselves in nursing homes, assisted living centers and adult care homes.
The Senate Finance Committee’s third drug-pricing hearing focused on pharmacy benefit managers, and was more of a fact-finding mission on how these companies operate than a debate about policy proposals.
Hospitals and nursing homes in California and Illinois hope that regional cooperation — and a special soap — will help them gain the upper hand against deadly antibiotic-resistant superbugs.
What to know about PBMs and rebates ahead of the Senate drug price hearing on — you guessed it — PBMs.
The soda industry spent $11.8 million to influence policy statewide in 2017 and 2018. As politicians once again consider bills that would tax and label sugary drinks, more big money is expected to flow.